Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-01-12 @ 11:20 AM
Study NCT ID:
NCT07235202
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-19
First Post:
2025-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
Sponsor:
Shenzhen Majory Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-22
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-06-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-22
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-14
First Submit QC Date:
None
Study First Post Date:
2025-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-19
Last Update Post Date Type:
ESTIMATED